Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease

    European Heart Journal Date published:

  • THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE

    Date published:

  • Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial

    Journal of Hypertension Date published:

  • Does interleukin-18 or tumour necrosis factor-α have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand

    Cytokine Date published:

  • Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy

    Stroke Date published:

  • Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

    Journal of Hypertension Date published:

  • Responding to China's hypertensive crisis

    The Lancet Date published:

  • Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): A factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India

    American Heart Journal Date published:

  • Risks of cardiovascular disease and severe hypoglycaemia according to cognitive function in people with type 2 diabetes in ADVANCE

    Date published:

  • Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

    Diabetologia Date published:

  • Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

    Journal of the American Society of Nephrology Date published:

  • Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes

    Diabetes Care Date published:

  • INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL

    Date published:

  • THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA

    Date published:

  • THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL

    Date published:

  • Reply

    Journal of the American College of Cardiology Date published: